Quadra Med India Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 04-07-2024
- Paid Up Capital ₹ 1.05 Cr
as on 04-07-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.20 Cr
as on 04-07-2024
- Revenue -69.00%
(FY 2022)
- Profit -423.36%
(FY 2022)
- Ebitda 8.21%
(FY 2022)
- Net Worth -4.06%
(FY 2022)
- Total Assets -11.20%
(FY 2022)
About Quadra Med India
The Corporate was formerly known as Quadra Foods India Private Limited. The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 1.05 Cr.
The company has closed loans amounting to ₹2.20 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sivaramakrishna Narayanaswamy, Ranganathan Madhavan, Madhavan Rajagopalan, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909TN2010PTC075213
- Company No.
075213
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai City Corporation, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Quadra Med India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhavan Rajagopalan  | Whole-Time Director | 31-Mar-2010 | Current |
| Sivaramakrishna Narayanaswamy | Whole-Time Director | 31-Mar-2010 | Current |
| Ranganathan Madhavan | Whole-Time Director | 19-Aug-2010 | Current |
| Gopalan Ganesan | Whole-Time Director | 31-Mar-2010 | Current |
Financial Performance of Quadra Med India.
Quadra Med India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 69% decrease. The company also saw a substantial fall in profitability, with a 423.36% decrease in profit. The company's net worth dipped by a decrease of 4.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quadra Med India?
In 2022, Quadra Med India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medi Focus India Private LimitedActive 18 years 7 monthsSivaramakrishna Narayanaswamy, Madhavan Rajagopalan and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 13 Feb 2015 | ₹1.10 Cr | Satisfied |
Bank Of Baroda Creation Date: 20 Jun 2013 | ₹1.10 Cr | Satisfied |
How Many Employees Work at Quadra Med India?
Unlock and access historical data on people associated with Quadra Med India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quadra Med India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quadra Med India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
